June 4, 2024 |
From 4 June 2024 AMICULUM is bringing together our family of agencies under the AMICULUM® brand. All of our agencies were founded and owned by AMICULUM and the business continues to be owned by its founders.
Our heritage agency teams coming together are:
All of our teams and expertise across therapy areas and specialisms will remain in place. We will continue to partner with healthcare clients and the medical community throughout the product lifecycle from early opportunity assessment to launch and beyond.
This integration of our teams under the AMICULUM brand will maximize the breadth of specialties that we can offer to all of our clients and give us even greater agility to respond to client needs in the ever-changing healthcare landscape.
Richard Allcorn (Co-founder of AMICULUM) said “After over 20 years of growth of AMICULUM as a family of specialist healthcare communication brands we are delighted to be integrating our teams into a single global agency focused on the delivery of transformative health communications in partnership with our clients”.
For further information on AMICULUM or our integration please contact Richard at Richard.Allcorn@amiculum.biz
About AMICULUM
Science underpins everything that we do at AMICULUM. We use our diverse experience to create compelling insights-based narratives and experiences that bring our clients’ data and brands to life for audiences from HCPs through to payers and patients.
Working in collaboration with our clients and the global medical community, our mission is to bring medical innovation to patients to enable the transformation of health.
![]()
This content was provided by Amiculum
Latest Content from Amiculum
We’re delighted that Amiculum has become a member of Bionow, joining a collaborative community that plays an important role in bringing together life sciences organizations across the North of the…
By Lottie Sequerra and Emily Morton-West
Amiculum is pleased to announce the relocation of its Dundee team to a new, state-of-the-art facility at the Dundee Life Sciences Innovation Hub, an environment designed to accelerate scientific progress…
By Zoë van Helmond
By Betty Charleshouse
Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines development, driving better outcomes, equity…
